找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Atypical Breast Proliferative Lesions and Benign Breast Disease; Farin Amersi,Kristine Calhoun Book 2018 Springer International Publishing

[复制链接]
楼主: adulation
发表于 2025-3-26 21:48:26 | 显示全部楼层
发表于 2025-3-27 01:18:48 | 显示全部楼层
Tom P. Evans,Glen M. Green,Laura A. Carlsonfetime risk of breast cancer is not dissimilar to patients with a genetic predisposition gene. In these women, surgical risk reduction may be considered, although medical prevention therapy is favored.
发表于 2025-3-27 05:35:48 | 显示全部楼层
发表于 2025-3-27 12:01:28 | 显示全部楼层
https://doi.org/10.1007/978-94-009-0005-9CIS deserves a careful discussion of the various treatment options, including accurate recurrence risk estimates and the relative importance to her of the risks and benefits of each option, to help her choose the optimal treatment for her.
发表于 2025-3-27 17:14:38 | 显示全部楼层
,Lobular Carcinoma In Situ: Risk Factor or Cancer Precursor?, as a precursor lesion for invasive cancer in some cases. The primary purpose of this chapter is to detail the evidence in support of the current view, LCIS as . a risk factor, conferring increased risk of both ipsilateral and contralateral invasive carcinoma, and a non-obligate precursor lesion at or near the site of the index lesion.
发表于 2025-3-27 20:42:29 | 显示全部楼层
,Ductal Carcinoma In Situ: Risk Factor or Cancer,arly cancer. While there is survival benefit with surgery and radiotherapy, treatment needs to be personalized, and better predictors of outcome need to be developed and tested in clinical trials to better implement therapeutic decision-making.
发表于 2025-3-28 00:23:18 | 显示全部楼层
发表于 2025-3-28 03:59:14 | 显示全部楼层
发表于 2025-3-28 06:52:43 | 显示全部楼层
Prophylactic Mastectomy in Patients with Atypical Breast Lesions,fetime risk of breast cancer is not dissimilar to patients with a genetic predisposition gene. In these women, surgical risk reduction may be considered, although medical prevention therapy is favored.
发表于 2025-3-28 11:25:08 | 显示全部楼层
The Nonsurgical Management of Ductal Carcinoma In Situ (DCIS),ed with surgical intervention. Alternative strategies harnessing immune responses, including vaccination, are underway. Quality of life and patient reported outcomes will also guide whether nonsurgical interventions may, in future, become standard of care for selected women with DCIS.
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-20 03:34
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表